Hello everyone! Sorry it's taken me so long to get to writing this blog post, my MS got in the way of my "to-do" list.
So, I wanted to share some exciting things I learned while at ECTRIMS in Lyon, France.
For one, there is a study that has been done on Copaxone that looks VERY promising, from what I've heard. Instead of a daily sub-q injection of Copaxone at 20mg a day, they are looking into the outcome of taking Copaxone 3-times a week, still sub-q, but at 40mg a day! I know that this is something to look forward to for many, to follow up on it and see if the outcome is promising. Here is some more information on the study:
http://www.clinicaltrials.gov/ct2/show/NCT00202982
http://www.clinicaltrials.gov/ct2/show/NCT01067521
So, as you can see... right now the approved dosage is a daily inecjtion of 20mg, under the skin. The study looked at doubling the approved dose but changing the frequency of the dosing.
While this is exciting news, we still don't know ALL of the information in regards to this study.
Does the new dosing change and/or intensify the injection-site reactions? Is there a higher chance of getting lipoatrophy (dimples in the skin) from the injections? Will the injection procedure be the same? Will the auto-inject be used and/or modified if this dosing becomes available?
I'm going to keep researching on this information and I will share anything I find.
If you want to know more about ECTRIMS 2012 - you can view Webcasts and see Posters/Presentations:
Webcasts: http://ectrims2012.eventresult.com/
Posters & Presentations: http://www.posters2view.com/ectrims2012/welcome.php
No comments:
Post a Comment